Tobacco products in the European Union Common Entry Gate (EU-CEG): A tool for monitoring the EU tobacco products directive.

CAS number EU-CEG Tobacco Products Directive cigarette characterizing flavor ingredients priority additives

Journal

Tobacco prevention & cessation
ISSN: 2459-3087
Titre abrégé: Tob Prev Cessat
Pays: Greece
ID NLM: 101693412

Informations de publication

Date de publication:
2022
Historique:
received: 05 08 2021
revised: 10 12 2021
accepted: 03 01 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 26 3 2022
Statut: epublish

Résumé

Under the European Union (EU) Tobacco Products Directive (2014/40/EU) (TPD), manufacturers and importers of tobacco products are required to report information to the European Commission (EC) and Member States (MS) on products intended to be placed on the market. We describe the distribution of notifications to the EU Common Entry Gate (EU-CEG) and identify key fields for improvement on reporting cigarettes or roll-your-own (RYO) tobacco. A cross-sectional analysis of secondary data reported in the EU-CEG was conducted for tobacco products notified within EU-CEG between June 2016 and October 2019 for 12 EU MS. Analysis of compliance to specific regulations for priority additives that refer to cigarettes and RYO was conducted for 10 EU countries. Overall, 39170 tobacco products were notified. This included 16762 (42.8%) notifications of cigars, followed by cigarettes 11242 (28.7 %), waterpipes 3291 (8.4%), cigarillos (n=1783), pipe (n=1715), RYO (n=1635), chewing tobacco (n=1021), novel tobacco products (n=839), herbal products for smoking (n=535), other (n=258), nasal (n=74) and oral tobacco (n=15). In cigarettes and RYO tobacco products, the proportion of ingredients notified in all countries that contained an unknown Chemical Abstract Services (CAS) number was 3.8% and 2.1%, respectively. The proportion of underreporting flagging of priority additives ranged from 15.9% in Malta to 41.3% in Lithuania, the mean proportion of underreporting of the variable 'priority additive' for the 10 countries together was 24.7%. In the EU-CEG data base, for the period of analysis, a significant number of product notifications took place while large variations in the number of types of tobacco products notified across EU countries was noted. The timely monitoring of these data is needed so that products non-compliant within the EU-CEG system are assessed.

Identifiants

pubmed: 35330752
doi: 10.18332/tpc/145501
pii: 10
pmc: PMC8889498
doi:

Types de publication

Journal Article

Langues

eng

Pagination

10

Informations de copyright

© Carnicer-Pont D. et al.

Déclaration de conflit d'intérêts

The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.

Références

Rev Esp Salud Publica. 2019 Aug 13;93:
pubmed: 31407675
Tob Control. 2021 Jan;30(1):57-62
pubmed: 31685584
Tob Control. 2021 Mar;30(2):185-191
pubmed: 32041831
Addiction. 2021 Sep;116(9):2521-2528
pubmed: 33651418

Auteurs

Dolors Carnicer-Pont (D)

Cancer Prevention and Control Programme, Cancer Epidemiology and Prevention Department, Catalan Institute of Oncology, Barcelona, Spain.
Tobacco Control Research Group, Epidemiology and Public Health Programme, Bellvitge Biomedical Research Institute, Barcelona, Spain.
School of Medicine and Clinical Sciences, University of Barcelona, Barcelona, Spain.
Centre for Biomedical Research Network, CIBERES, Madrid, Spain.

Olena Tigova (O)

Cancer Prevention and Control Programme, Cancer Epidemiology and Prevention Department, Catalan Institute of Oncology, Barcelona, Spain.
Tobacco Control Research Group, Epidemiology and Public Health Programme, Bellvitge Biomedical Research Institute, Barcelona, Spain.
School of Medicine and Clinical Sciences, University of Barcelona, Barcelona, Spain.
Centre for Biomedical Research Network, CIBERES, Madrid, Spain.

Anne Havermans (A)

Centre for Health Protection, National Institute for Public Health and the Environment, RIVM, Bilthoven, The Netherlands.

Eline Remue (E)

Federal Public Service Health, Food Chain Safety and Environment, Brussels, Belgium.

Matus Ferech (M)

Tobacco Control Team, DG SANTE B2, Cross-border Healthcare and Tobacco Control, Brussels, Belgium.

Katharina Vejdovszky (K)

Austrian Agency for Health and Food Safety, Vienna, Austria.

Renata Solimini (R)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy.

Silvano Gallus (S)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy.

Emilia Nunes (E)

Department of Health, Ministry of Health, Lisbon, Portugal.

Carl C Lange (CC)

The Danish Safety Technology Authority, Copenhagen, Denmark.

Cristina Gomez-Chacon (C)

Tobacco Prevention and Control Unit, Deputy Direction of Promotion, Prevention and Quality, General Direction of Public Health, Ministry of Health, Madrid, Spain.

Francisco Ruiz-Dominguez (F)

General Directorate of Public Health and Pharmaceutical Management, Regional Ministry of Health and Families of Andalusia, Sevilla, Spain.

Panagiotis Behrakis (P)

George D. Behrakis Research Lab, Hellenic Cancer Society, Athens, Greece.

Constantine I Vardavas (CI)

George D. Behrakis Research Lab, Hellenic Cancer Society, Athens, Greece.

Esteve Fernandez (E)

Cancer Prevention and Control Programme, Cancer Epidemiology and Prevention Department, Catalan Institute of Oncology, Barcelona, Spain.
Tobacco Control Research Group, Epidemiology and Public Health Programme, Bellvitge Biomedical Research Institute, Barcelona, Spain.
School of Medicine and Clinical Sciences, University of Barcelona, Barcelona, Spain.
Centre for Biomedical Research Network, CIBERES, Madrid, Spain.

Classifications MeSH